Written by Fertility Decoded. Reviewed by D R, MS (OBG), FRM. Review date: 31 August 2026.
The verdict
An animal pregnancy-exposure study found estrogenic tissue changes on the exact gestation window a trying-to-conceive user could unknowingly be in; its main real-world use (as a lactation aid) rests on weak or manufacturer-funded human evidence, not independent proof it works.
An Ayurvedic root, traditionally used as a women's reproductive tonic and, especially, as a postpartum lactation aid — the latter is its dominant real-world use case in India.
What the evidence shows
1Fertility/menopause evidence: recent trials exist for sexual wellness and menopausal symptoms (RCTs, 100+ participants); a 2025 fertility-specific review calls the herb "promising" but says fertility-specific trials remain limited, especially for male fertility where evidence is essentially absent.
2Lactation evidence (its main marketed use): one human trial measured only a prolactin surrogate, not milk output; the one trial that measured actual milk volume and found a difference was funded by, and co-authored with a director of, the company that makes the branded product tested (ACT Lifesciences / Shavari Bar®) — a direct conflict of interest. A 2013 systematic review found the overall evidence for herbal galactogogues, shatavari included, inadequate to guide clinical recommendations.
Evidence tier
⛔Documented harm
⛔ Peer-reviewed evidence of serious adverse effects from the item's own chemistry/pharmacology or a well-characterized allergic mechanism. More serious than contamination; not resolved by buying a 'reputable brand'.
Frequently asked questions
Does shatavari help fertility or milk supply?▾
Fertility-specific trials are limited; its main use (lactation) rests on weak or manufacturer-funded evidence.
Is shatavari safe in early pregnancy?▾
An animal study found estrogenic tissue changes on gestation days 1–15 — exactly the window a trying-to-conceive user could unknowingly be in. Caution is warranted; discuss with a doctor.